Modulation of dysarthropneumophonia by low-frequency STN DBS in advanced Parkinson's disease

Mov Disord. 2011 Mar;26(4):659-63. doi: 10.1002/mds.23538.

Abstract

Background: Parkinsonian dysarthria (as typically characterized by hypophonia, monotony of pitch, and rhythm abnormalities) is often accompanied by gait disturbances. The long-term effect of subthalamic nucleus deep brain stimulation (STN DBS) on dysarthria remains unclear.

Methods: Given STN DBS's known improvement of gait disorders, we analyzed speech intelligibility and aerodynamic and acoustic parameters in 11 advanced PD patients in three double-blind, randomized conditions: "defined Off," 60 Hz STN DBS and 130 Hz STN DBS.

Results: An improvement in aerodynamic speech parameters during 60 Hz STN DBS was accompanied by significant clinical benefit.

Conclusions: Chronic treatment with low-frequency STN DBS may have a beneficial impact on dysarthropneumophonia, even in advanced PD patients.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Deep Brain Stimulation / methods*
  • Disability Evaluation
  • Female
  • Humans
  • Male
  • Parkinson Disease / complications*
  • Parkinson Disease / therapy
  • Severity of Illness Index
  • Speech Disorders / etiology*
  • Speech Disorders / therapy*
  • Subthalamic Nucleus / physiology*
  • Voice Disorders / etiology*
  • Voice Disorders / therapy*